Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GNOS-PV02 |
| Synonyms | |
| Therapy Description |
GNOS-PV02 is a personalized neoantigen cancer vaccine comprising a DNA plasmid encoding upto 40 patient-derived neoantigens, which may induce antitumor immune response and inhibit tumor growth (PMID: 38584166). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GNOS-PV02 | GNOS-PV2|GNOS PV02|GNOS PV2\GNOSPV02 | GNOS-PV02 is a personalized neoantigen cancer vaccine comprising a DNA plasmid encoding upto 40 patient-derived neoantigens, which may induce antitumor immune response and inhibit tumor growth (PMID: 38584166). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|